LRCX stock trades near its 52-week range as Lam Research expands margins

Lam Research (US5184391044) remains a large semiconductor equipment name, with fiscal 2025 revenue of $17.6 billion, gross margin of 47.1%, and operating income of $5.2 billion in the company’s latest annual reporting cycle. Those figures frame LRCX stock even on a thin news day, because they show the scale of the business that still anchors the shares.

Fiscal 2025 sets the base

For fiscal 2025, Lam Research reported revenue of $17.6 billion, compared with $14.9 billion in fiscal 2024, a gain of about 18.1% year over year. Gross margin was 47.1% in fiscal 2025, while operating income reached $5.2 billion, a useful reminder that profitability remained substantial at the same time sales expanded.

Net income for fiscal 2025 was $4.7 billion, versus $3.7 billion in fiscal 2024, and diluted EPS rose to $3.58 from $2.72 over the same period. That combination of higher revenue and better per-share earnings gives the stock a clear reported fundamental base.

Margins still matter

The margin profile is the most readable part of the story. A 47.1% gross margin in fiscal 2025 means Lam Research kept nearly half of revenue after cost of goods sold, while $5.2 billion of operating income shows that operating leverage stayed intact.

Investors usually map that structure against the cycle in wafer fabrication equipment spending. When the top line moves by 18.1% year over year and EPS moves from $2.72 to $3.58, the market tends to focus less on generic semiconductor sentiment and more on how durable the earnings mix is.

Trading context for LRCX stock

In market context, LRCX stock is commonly watched on Nasdaq, where the shares are tied to the broader semiconductor capital-equipment trade. The most useful framing is still numerical: the company’s latest reported $17.6 billion revenue base, $4.7 billion net income, and 47.1% gross margin create a valuation anchor even when no fresh catalyst is in the foreground.

Semiconductor equipment exposure

Lam Research operates in wafer fabrication equipment, so the stock is closely linked to spending on etch and deposition tools across advanced chip production. That exposure matters because revenue of $17.6 billion in fiscal 2025 and operating income of $5.2 billion show how much earnings power sits inside the equipment cycle.

The same fiscal year also produced diluted EPS of $3.58 and net income of $4.7 billion, which makes the company easier to compare with other capital-intensive semiconductor suppliers. For readers tracking the sector, those are the numbers that matter more than broad thematic labels.

Margins and earnings mix

Lam Research’s fiscal 2025 gross margin of 47.1% is a key signpost because it helps explain why earnings can move faster than revenue in a strong cycle. The year-over-year revenue increase of 18.1% to $17.6 billion and the rise in net income to $4.7 billion show that the company was converting sales into profit at a high rate.

That profit conversion is what keeps LRCX stock on traders’ screens during periods when the wider chip-equipment group is being repriced. A business that can hold a 47.1% gross margin while earning $5.2 billion in operating income remains highly sensitive to order timing, customer spending patterns, and any shift in capex budgets.

Product line focus

Lam Research’s core product set is tied to wafer etch and deposition tools used in semiconductor manufacturing. Those categories matter because they sit close to the process steps that define chip performance, and the fiscal 2025 numbers show the scale at which that equipment base still operates.

The company’s reported $17.6 billion revenue, $4.7 billion net income, and $3.58 diluted EPS are the cleanest way to track how that product mix translated into financial results over the year.

Stock closing view

LRCX stock is best read through the latest reported annual numbers rather than a single headline move. The relevant anchor points remain fiscal 2025 revenue of $17.6 billion, gross margin of 47.1%, operating income of $5.2 billion, and diluted EPS of $3.58.